ProMIS Neurosciences Inc (NASDAQ: PMN) kicked off on Monday, up 33.20% from the previous trading day, before settling in for the closing price of $0.39. Over the past 52 weeks, PMN has traded in a range of $0.38-$2.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -695.45%. With a float of $23.12 million, this company’s outstanding shares have now reached $32.69 million.
In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
ProMIS Neurosciences Inc (PMN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of ProMIS Neurosciences Inc is 29.28%, while institutional ownership is 24.09%. The most recent insider transaction that took place on Feb 10 ’25, was worth 14,595. In this transaction Chief Scientific Officer of this company bought 15,000 shares at a rate of $0.97, taking the stock ownership to the 16,617 shares. Before that another transaction happened on Sep 24 ’24, when Company’s Director bought 70,000 for $1.30, making the entire transaction worth $91,028. This insider now owns 208,333 shares in total.
ProMIS Neurosciences Inc (PMN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -695.45% per share during the next fiscal year.
ProMIS Neurosciences Inc (NASDAQ: PMN) Trading Performance Indicators
Take a look at ProMIS Neurosciences Inc’s (PMN) current performance indicators. Last quarter, stock had a quick ratio of 3.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of ProMIS Neurosciences Inc (PMN)
Let’s dig in a bit further. During the last 5-days, its volume was 19.6 million. That was better than the volume of 0.79 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.90%.
During the past 100 days, ProMIS Neurosciences Inc’s (PMN) raw stochastic average was set at 16.09%, which indicates a significant increase from 16.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0898 in the past 14 days, which was higher than the 0.0724 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5004, while its 200-day Moving Average is $0.7942. However, in the short run, ProMIS Neurosciences Inc’s stock first resistance to watch stands at $1.0367. Second resistance stands at $1.5533. The third major resistance level sits at $1.8567.
ProMIS Neurosciences Inc (NASDAQ: PMN) Key Stats
The company with the Market Capitalisation of 17.00 million has total of 32,689K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of 2,780 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,350 K.
